$1.54 -0.00 (-0.08%)

AquaBounty Technologies, Inc. (AQB)

AquaBounty Technologies, Inc. is a biotechnology company focused on the development and commercialization of genetically modified aquatic organisms, primarily salmon. The company's flagship product is the AquAdvantage Atlantic salmon, engineered to grow faster than conventional salmon. AquaBounty aims to provide sustainable and efficient seafood solutions through innovative genetic technology, addressing global food security and reducing the environmental impact of aquaculture.

🚫 AquaBounty Technologies, Inc. does not pay dividends

Company News

Shenandoah Telecommunications Appoints Angela M. Olsen as General Counsel
GlobeNewswire Inc. • Angela M. Olsen • August 25, 2025

Shentel has appointed Angela M. Olsen as Vice President-Legal and General Counsel, bringing over 25 years of legal experience from various corporate and government roles.

AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research • Zacks Equity Research • May 15, 2024

AquaBounty Technologies (AQB) delivered earnings and revenue surprises of -7.75% and 4.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Benzinga • Lisa Levin • October 16, 2023

Gainers LQR House Inc. (NASDAQ: LQR) shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugural order to Costco, securing Von Payne Whiskey's presence on store shelves. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) shares rose 84.4% to $0.8853 in pre-market trading after jumping 45% on Friday. MingZhu Logistics Ho...

4 Penny Stocks With Huge Potential According To Analyst Forecasts
PennyStocks • J. Samuel • March 10, 2022

4 Hot Penny Stocks To Buy According To Analysts. The post 4 Penny Stocks With Huge Potential According To Analyst Forecasts appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

ARK Genomic Revolution ETF: Value Realization Will Take Time
Seeking Alpha • Mercury Research • May 3, 2021

While the growth story sounds exciting on ARKG, its valuations are pretty high. Here's how to play it.